Ro5

London, United Kingdom Founded: 2018 • Age: 8 yrs Acquired By Juvenescence
AI-based drug discovery management tool is provided for researchers.
Request Access

About Ro5

Ro5 is a company based in London (United Kingdom) founded in 2018 by Will Montgomery, Roy Tal, and Zygimantas Jocys was acquired by Juvenescence in April 2025.. Ro5 operates in a competitive market with competitors including Helix, Owkin, Formation Bio, Benchling and AbSci, among others.

  • Headquarter London, United Kingdom
  • Founders Will Montgomery, Roy Tal, Zygimantas Jocys
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Juvenescence

    (Apr 01, 2025)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Ro5
Headcount 10-50
Employee Profiles 4
Board Members and Advisors 8
Employee Profiles
People
Will Montgomery
General Counsel
People
Charles Dazler Knuff
Founding CEO
People
Tanya Paquet
Ro5 Leadership Team

Unlock access to complete

Board Members and Advisors
people
John Howe
Advisor
people
Jeffrey Kindler
Advisor
people
Carol Routledge
Advisor
people
Robert Collins
Advisor

Unlock access to complete

Funding Insights of Ro5

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Ro5

Ro5 has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Juvenescence. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Provider of proprietary ketone ester-based therapeutic drink for age-related disorders and metabolic health
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Ro5

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Ro5

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Ro5 Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Ro5

Ro5 operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Owkin, Formation Bio, Benchling and AbSci, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Genomic database for clinical research is provided.
domain founded_year HQ Location
An agentic AI platform is developed for biomedical research insights.
domain founded_year HQ Location
AI-powered drug discovery platform for various diseases
domain founded_year HQ Location
Cloud-based bioinformatics platform is offered for biotech research.
domain founded_year HQ Location
AI-based technology is used for recombinant protein production in therapeutics.
domain founded_year HQ Location
Bioinformatics platform is provided for biomarkers and drug discovery.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Ro5

Frequently Asked Questions about Ro5

When was Ro5 founded?

Ro5 was founded in 2018.

Where is Ro5 located?

Ro5 is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.

What does Ro5 do?

Ro5 was founded in 2018 in London, United Kingdom, and operates in the biotechnology sector. An AI-driven platform is offered to support drug development strategies through database management. Features include tools for pharmacological studies, bioactivity analysis, and clinical trial evaluation. Assistance is provided to researchers in streamlining workflows and data handling within the pharmaceutical research domain.

Who are the top competitors of Ro5?

Ro5's top competitors include Owkin, Helix and Formation Bio.

Who are Ro5's investors?

Ro5 has 1 investor. Key investors include Juvenescence.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available